📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Invivodata

1.1 - Company Overview

Invivodata Logo

Invivodata

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of electronic patient-reported outcomes (ePRO) solutions and services for clinical trials, offering patient data collection, data management, and clinical outcome assessments software. Offers DiaryPRO electronic patient diary and DiaryPRO Web for PRO data collection via a web interface, and provides SitePRO, helping worldwide clinical trial sponsors assess the effectiveness of new medical products.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Invivodata

ConcertAI Logo

ConcertAI

HQ: United States Website
  • Description: Provider of AI-powered SaaS medical research tools and integrated real-world data solutions for oncology. Offerings include AI-enriched datasets for clinical and outcomes research, regulatory-grade external control arms, pragmatic trials, post-approval studies, virtual EMR-claims registries, and regulatory research with custom real-world data abstraction and scientific consultation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ConcertAI company profile →
Genuity Science Logo

Genuity Science

HQ: United States Website
  • Description: Provider of clinco-omics data analysis solutions and genomic sequence data for researchers, with a platform for study design, sequencing, storage, interpretation, secondary analysis, and scalable analytics. Offers disease-specific clinical omics datasets (CNS, cardiometabolic, inflammatory), powered datasets, deeply phenotyped whole genomes, longitudinal data, and population-scale expertise applying deep learning to improve patient health using the human genome.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genuity Science company profile →
MDC Partners Logo

MDC Partners

HQ: Belgium Website
  • Description: Provider of business intelligence solutions for clinical trial optimization, medical expert identification and competitive intelligence, leveraging data mining, semantic processing and engineering to deliver event-based tools to monitor and analyze.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MDC Partners company profile →
OMNY Health Logo

OMNY Health

HQ: United States Website
  • Description: Provider of a healthcare data sharing and research platform connecting providers and life sciences to improve patient care and drive innovation; real-world data solutions with comprehensive patient data; operational and clinical decision-making tools; custom data and dashboards; medical device insights; and social determinants of health datasets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OMNY Health company profile →
CluePoints Logo

CluePoints

HQ: United States Website
  • Description: Provider of cloud-based risk-based monitoring and central statistical monitoring solutions for clinical trials, using its patented SMART engine to analyze clinical and operational data, assess data quality, accuracy, and integrity, and detect atypical patterns indicating sloppiness, tampering, systemic errors, or fraud. Offers key risk indicators, quality tolerance limits, duplicate patient detection, patient profiles, and business intelligence, aligned with ICH, FDA, and EMA guidance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CluePoints company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Invivodata

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Invivodata

2.2 - Growth funds investing in similar companies to Invivodata

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Invivodata

4.2 - Public trading comparable groups for Invivodata

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Invivodata

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Invivodata

What does Invivodata do?

Invivodata is a provider of electronic patient-reported outcomes (ePRO) solutions and services for clinical trials, offering patient data collection, data management, and clinical outcome assessments software. Offers DiaryPRO electronic patient diary and DiaryPRO Web for PRO data collection via a web interface, and provides SitePRO, helping worldwide clinical trial sponsors assess the effectiveness of new medical products.

Who are Invivodata's competitors?

Invivodata's competitors and similar companies include ConcertAI, Genuity Science, MDC Partners, OMNY Health, and CluePoints.

Where is Invivodata headquartered?

Invivodata is headquartered in United States.

How many employees does Invivodata have?

Invivodata has 1,000 employees 🔒.

When was Invivodata founded?

Invivodata was founded in 2010 🔒.

What sector and industry vertical is Invivodata in?

Invivodata is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Invivodata

Who are the top strategic acquirers in Invivodata's sector and industry

Top strategic M&A buyers and acquirers in Invivodata's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Invivodata?

Top strategic M&A buyers groups and sectors for Invivodata include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Invivodata's sector and industry vertical

Which are the top PE firms investing in Invivodata's sector and industry vertical?

Top PE firms investing in Invivodata's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Invivodata's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Invivodata's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Invivodata's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Invivodata include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Invivodata's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Invivodata?

The key public trading comparables and valuation benchmarks for Invivodata include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Invivodata for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Invivodata with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Invivodata's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Invivodata with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Invivodata's' sector and industry vertical?

Access recent funding rounds and capital raises in Invivodata's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Invivodata

Launch login modal Launch register modal